ClinicalTrials.gg
Enrolling by invitationNCT06892795Updated Mar 26, 2025

Constructing a Risk Prediction Model for Intraoperative Hypothermia in Children Under General Anesthesia

An observational study in Hypothermia, Accidental and Hypothermia; Anesthesia, sponsored by Harbin Medical University. Enrolling by invitation at 1 site in China. Open to participants aged Up to 15 Years. Per ClinicalTrials.gov, last updated 2025-03-26.

Sponsored by Harbin Medical University · Observational

From the registry’s dates

  • Primary completion was expected by Jun 2026, 5 months ago, but the record still lists the study as enrolling by invitation.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
562
Ages
Up to 15 Years
Sex
All
01

Study summary

Intraoperative hypothermia refers to a core body temperature below 36.0°C during surgery, which is common in surgical patients. Due to the fact that children's body temperature regulation function is not yet fully developed, they are light in weight, and their blood vessels are superficial, children are very susceptible to the influence of environmental temperature. With the effects of anesthetic drugs, exposure of the surgical field, and disinfection of the surgical area, children face a higher risk of intraoperative hypothermia than adult patients. Studies have shown that the incidence of intraoperative hypothermia can be as high as 80%. Intraoperative hypothermia can lead to increased adverse cardiovascular events, poor coagulation, slower healing of surgical incisions, or wound infection, threatening the health of children, resulting in prolonged postoperative hospitalization and increased hospitalization costs. Therefore, there is an urgent need to develop a tool for predicting intraoperative hypothermia suitable for children, identify high-risk groups early, and take preventive measures as soon as possible, thereby reducing a series of complications caused by hypothermia. The purpose of this study is to clarify the current status and risk factors affecting intraoperative hypothermia in children, to provide a theoretical basis for clinical medical staff to provide intraoperative thermal insulation care for children, and on this basis to construct an intraoperative hypothermia risk prediction model to identify the probability of hypothermia in children at an early stage, so as to take targeted thermal insulation measures.

Read the detailed description

The study first clarified the overall incidence and influencing factors of IOH in children through meta-analysis, combined with expert consultation to determine potential predictive variables, and developed a data questionnaire for this study. The second part of the study will collect data prospectively, use four algorithms in machine learning, including logistic regression, decision tree, random forest, and support vector machine, to build an excellent intraoperative hypothermia risk prediction model, and conduct internal verification of the model. The third part of the study prospectively collects sample data to complete external verification of time period and space. The constructed model still has good predictive ability in the new data set. Finally, some models are visualized to form intuitive and easy-to-understand charts or interfaces.

02

Conditions studied

  • Hypothermia, Accidental
  • Hypothermia; Anesthesia

Browse trials for

03

In context

Hypothermia

449 studies on the registry are indexed under Hypothermia; 54 are open to participants now.

This study's planned enrollment of 562 is above the median of 95 across 106 observational studies indexed under Hypothermia.

Browse Hypothermia studies →

Lead sponsor

Harbin Medical University is the lead sponsor of 88 studies on the registry; 30 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 15 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Pediatric surgical patients receiving general anesthesia

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age \< 16 years old;
  • Anesthesia includes general anesthesia;
  • Anesthesia duration > 30 minutes.

Exclusion criteria

Exclusion Criteria:

  • Cardiac surgery or other procedures that require lowering the child's body temperature;
  • Refusing to participate in this study;
  • >Ⅳ;
  • Abnormal basal body temperature, preoperative core body temperature \<36.0℃ or >38.0℃;
  • Hyperthyroidism or hypothyroidism and other diseases that affect body temperature;
  • The core body temperature cannot be measured due to surgery or ear canal disease.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
562 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes
Biospecimen retention
Samples without dna

Groups and cohorts

  • Hypothermia

    Core body temperature below 36°C during surgery

  • Non-hypothermia

    Core body temperature ≥ 36°C during surgery

06

What researchers measure

Primary outcomes

  1. Core body temperature

    Use an infrared electronic ear thermometer to measure the child's eardrum temperature as the core body temperature.

    Time frame: The investigators will measure the child's core body temperature when the child enters the operating room, after induction of anesthesia, and then every 30 minutes until the end of the operation.

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2024 (actual). Primary completion is estimated for Jun 2026, 22 months after the start.

Of 47 non-industry observational studies under Hypothermia, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 50. This study's planned 22 months is above that.

Counting every sponsor, half of 48 studies reached it within 12 months; a quarter within 4 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 5, 2025
First posted
Mar 25, 2025
StartActual
Jul 15, 2024
Primary completionEst.
Jun 1, 2026
CompletionEst.
Jun 1, 2026
Last update
Mar 26, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06892795
Lead sponsor
Harbin Medical University
Responsible party
Huanglu Lan (Principal Investigator, Harbin Medical University) — Principal investigator
First posted
Mar 25, 2025
Start date
Jul 15, 2024
Primary completion
Jun 1, 2026 (estimated)
Completion
Jun 1, 2026 (estimated)
Last update
Mar 26, 2025

Study contacts

Huanglu Lan
principal investigator · The Sixth Affiliated hospital of Harbin Medical University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion